國立虎尾科技大學 |

Helicobacter pylori and gastric cancer

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Helicobacter pylori and gastric cancer/ edited by Steffen Backert.
其他作者:	Backert, Steffen.
出版者:	Cham :Springer Nature Switzerland : : 2023.,
面頁冊數:	xxix, 304 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Pathogenesis. -
電子資源:	https://doi.org/10.1007/978-3-031-47331-9
ISBN:	9783031473319

Helicobacter pylori and gastric cancer
Helicobacter pylori and gastric cancer[electronic resource] /edited by Steffen Backert. - Cham :Springer Nature Switzerland :2023. - xxix, 304 p. :ill. (some col.), digital ;24 cm. - Current topics in microbiology and immunology,v. 4442196-9965 ;. - Current topics in microbiology and immunology ;v.355..

Gastric stem cell biology and Helicobacter pylori infection -- Clinical pathogenesis and molecular mechanisms of gastric cancerogenesis -- Helicobacter pylori metabolism and mitochondrial dysfunction in gastric cancer development -- Immune biology and persistence of Helicobacter pylori in gastric diseases -- Pathogenomics of Helicobacter pylori infection -- Helicobacter pylori interactions with the microbiota and gastric cancer development -- Helicobacter pylori-induced host cell DNA damage and gastric carcinogenesis -- Gastric inflammation and oncogenic signal transduction networks by Helicobacter pylori -- Impact of Helicobacter pylori oncoprotein CagA and vacuolating cytotoxin VacA in gastric cancer -- Role of proteases in Helicobacter pylori infections and gastric diseases -- Clinical management of gastric cancer treatment regimes.

This volume explores in detail the molecular biology, genetics and immunology of the bacterium Helicobacter pylori that causes serious gastric diseases such as gastric cancer. The book provides in-depth insights into the mechanisms of H. pylori-induced pathogenicity, gives an overview of how the bacterium colonizes the human gut, how it manages to persist in the body and which factors play a role in the development of H. pylori-induced gastric cancer. Furthermore, the interaction between the Gram-negative bacterium and the human gut microbiome is explored, and clinical management and treatment strategies to combat gastric cancer are discussed. Helicobacter pylori is an extremely successful pathogen that persistently colonizes the gut of about 50% of the world's population. H. pylori and its human host share a long co-evolutionary relationship that dates back for at least last 100,000 years and possibly longer. Infection by this bacterium is a high-risk factor for the development of gastric diseases, including gastric cancer. Gastric cancer is associated with high morbidity and mortality and represents the 5th most common malignant tumour and the 4th leading cause of cancer-related death worldwide. H. pylori is the first bacterium that has been classified as a type-I carcinogen by the International Agency for Research on Cancer (IARC) Recent research progress identified crucial bacterial, host and environmental factors which control H. pylori-induced gastric malignancy. New studies also suggest that specific human germline mutations and other genetic aberrations have an important impact on H. pylori-induced pathology. In this volume, all these recently discovered mechanisms are reviewed in the light of gastric cancer development, and H. pylori epidemiology, virulence factors, immune evasion, pathophysiology, cancer signalling and novel therapeutic protocols are presented. This volume is aimed at researchers in the fields of immunology, genetics, microbiology and medicine who are interested in the detailed mechanisms of the pathogenicity of this carcinogenic stomach bacterium.

ISBN: 9783031473319

Standard No.: 10.1007/978-3-031-47331-9doiSubjects--Topical Terms:

1390667
Pathogenesis.

LC Class. No.: RC840.H38

Dewey Class. No.: 616.33014

Helicobacter pylori and gastric cancer
LDR:04009nam a2200337 a 4500 001 1120788
003 DE-He213
005 20240117162659.0
006 m d
007 cr nn 008maaau
008 240612s2023 sz s 0 eng d
020 $a 9783031473319 $q (electronic bk.)
020 $a 9783031473302 $q (paper)
024 7 $a 10.1007/978-3-031-47331-9 $2 doi
035 $a 978-3-031-47331-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC840.H38
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 616.33014 $2 23
090 $a RC840.H38 $b H475 2023
245 0 0 $a Helicobacter pylori and gastric cancer $h [electronic resource] / $c edited by Steffen Backert.
260 $a Cham : $c 2023. $b Springer Nature Switzerland : $b Imprint: Springer,
300 $a xxix, 304 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Current topics in microbiology and immunology, $x 2196-9965 ; $v v. 444
505 0 $a Gastric stem cell biology and Helicobacter pylori infection -- Clinical pathogenesis and molecular mechanisms of gastric cancerogenesis -- Helicobacter pylori metabolism and mitochondrial dysfunction in gastric cancer development -- Immune biology and persistence of Helicobacter pylori in gastric diseases -- Pathogenomics of Helicobacter pylori infection -- Helicobacter pylori interactions with the microbiota and gastric cancer development -- Helicobacter pylori-induced host cell DNA damage and gastric carcinogenesis -- Gastric inflammation and oncogenic signal transduction networks by Helicobacter pylori -- Impact of Helicobacter pylori oncoprotein CagA and vacuolating cytotoxin VacA in gastric cancer -- Role of proteases in Helicobacter pylori infections and gastric diseases -- Clinical management of gastric cancer treatment regimes.
520 $a This volume explores in detail the molecular biology, genetics and immunology of the bacterium Helicobacter pylori that causes serious gastric diseases such as gastric cancer. The book provides in-depth insights into the mechanisms of H. pylori-induced pathogenicity, gives an overview of how the bacterium colonizes the human gut, how it manages to persist in the body and which factors play a role in the development of H. pylori-induced gastric cancer. Furthermore, the interaction between the Gram-negative bacterium and the human gut microbiome is explored, and clinical management and treatment strategies to combat gastric cancer are discussed. Helicobacter pylori is an extremely successful pathogen that persistently colonizes the gut of about 50% of the world's population. H. pylori and its human host share a long co-evolutionary relationship that dates back for at least last 100,000 years and possibly longer. Infection by this bacterium is a high-risk factor for the development of gastric diseases, including gastric cancer. Gastric cancer is associated with high morbidity and mortality and represents the 5th most common malignant tumour and the 4th leading cause of cancer-related death worldwide. H. pylori is the first bacterium that has been classified as a type-I carcinogen by the International Agency for Research on Cancer (IARC) Recent research progress identified crucial bacterial, host and environmental factors which control H. pylori-induced gastric malignancy. New studies also suggest that specific human germline mutations and other genetic aberrations have an important impact on H. pylori-induced pathology. In this volume, all these recently discovered mechanisms are reviewed in the light of gastric cancer development, and H. pylori epidemiology, virulence factors, immune evasion, pathophysiology, cancer signalling and novel therapeutic protocols are presented. This volume is aimed at researchers in the fields of immunology, genetics, microbiology and medicine who are interested in the detailed mechanisms of the pathogenicity of this carcinogenic stomach bacterium.
650 2 4 $a Pathogenesis. $3 1390667
650 2 4 $a Bacteria. $3 600016
650 2 4 $a Cancer Biology. $3 1388882
650 1 4 $a Medical Microbiology. $3 668401
650 0 $a Stomach $x Immunology. $3 1436276
650 0 $a Stomach $x Cancer. $3 674283
650 0 $a Helicobacter pylori. $3 1108337
700 1 $a Backert, Steffen. $3 889235
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a Current topics in microbiology and immunology ; $v v.355. $3 882363
856 4 0 $u https://doi.org/10.1007/978-3-031-47331-9
950 $a Medicine (SpringerNature-11650)